KRT20 and transitional cell carcinoma: The CK20 immunostaining assay was found to be more sensitive to detecting stage pT1 (81.8% vs. 59.1%), grade 2 (76.2% vs. 61.9%), and grade 3 (82.1% vs. 67.9%) transitional cell carcinoma.